Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00068185 · ClinicalTrials.gov registry record · Phase 1
A Study of the Pharmacokinetics of Black Cohosh
A Phase 1 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Terminated
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT00068185 is a Phase 1 study that was terminated before completion, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 12 participants.
The verdict
NCT00068185, a Phase 1 study, was terminated before completion, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
Black cohosh is a natural supplement that has been used to treat and prevent menopausal symptoms. Remifemin is a standardized form of black cohosh. The purpose of this study is to determine the levels of components of black cohosh obtained in the blood of healthy women taking Remifemin.
Interventions
- DRUG Black cohosh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2003-08 |
| Est. Completion | 2008-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00068185
The ClinicalTrials.gov registry entry for NCT00068185 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Black cohosh is the first listed.
NCT00068185 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00068185 about?
NCT00068185 is a clinical study titled "A Study of the Pharmacokinetics of Black Cohosh". Black cohosh is a natural supplement that has been used to treat and prevent menopausal symptoms. Remifemin is a standardized form of black cohosh. The purpose of this study is to determine the levels of components of black cohosh obtained in the blood of healthy women taking Remifemin.
What is the current status of trial NCT00068185?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2003-08. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00068185?
The interventions under investigation include: Black cohosh (DRUG).
Who is sponsoring clinical trial NCT00068185?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.